Locations:
Search IconSearch

Image of Note: 3-D Radiation-Free Navigation of the Aorta

Endovascular navigation technology clears first preclinical study

Centerline Biomedical IOPS

Endovascular repair of aortic aneurysms and dissections is critically dependent on optimal understanding of the patient’s vasculature. To that end, Cleveland Clinic Innovations spinoff company Centerline Biomedical Inc. is refining development of its Intraoperative Positioning System (IOPS), a novel endovascular navigation technology developed by Cleveland Clinic researchers.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

IOPS extracts the centerlines of the aorta and branch vessels from a patient’s CT and then mathematically constructs a high-quality three-dimensional model of the relevant vasculature, as shown in the image above. Electromagnetic tracking technology allows the model to be used in a GPS-like fashion to guide surgeons during minimally invasive endovascular aortic repairs, enabling less reliance on X-ray fluoroscopy.

The first preclinical in vivo study of IOPS was completed in May 2016 at Cleveland Clinic Lerner Research Institute. It demonstrated the system’s ability to provide non-radiation-based navigation with superior visualization compared with X-ray fluoroscopy, which is limited by its two-dimensional visualization and by the radiation exposure it confers on patients and providers.

“Preclinical evaluation verified the ability to use this navigation system in manipulating through the aorta and its branches in the absence of radiation-inducing fluoroscopy,” says Cleveland Clinic vascular surgeon Matthew Eagleton, MD, who led the study. Noting that catheters and guidewires were easily visualized on the IOPS display, he predicted that the system “will be a game changer in the era of endovascular therapy.”

Centerline Biomedical plans to submit IOPS for FDA review, with a target market entry in the third quarter of 2017.

Advertisement

Related Articles

illustration of human heart with a graft repair
Novel Technique for Aortic Stenosis and Patient-Prosthesis Mismatch With LVOT Obstruction

Modified-Bentall single-patch Konno enlargement (BeSPoKE) optimizes hemodynamics, facilitates future TAVR

red blood cells floating around a DNA double helix
CHIP Cardiology Clinics Are Needed as CHIP Diagnoses Rise

Cleveland Clinic’s new dedicated program offers nuanced care for a newly recognized cardiovascular risk factor

side-by-side photos of heart valves during surgery
Special Considerations in Mitral Valve Repair: Barlow’s Valve, Barlow’s Syndrome and Arrhythmias

Scenarios where experience-based management nuance can matter most

Dr. Krishna Aragam with a patient
Genomics in Action: Advancing Precision Care for Inherited Heart Disease

Introducing Krishna Aragam, MD, head of new integrated clinical and research programs in cardiovascular genomics

scan of an implanted stented heart valve
Transcatheter Mitral Valve Replacement: Progress for the Most Challenging Mitral Valve Cases

How Cleveland Clinic is using and testing TMVR systems and approaches

illustrations of two valve procedures with "Vs." overlay spanning them
M-TEER or Surgical Repair? PRIMARY Trial Aims to Define Which Patients Are Best Served by Each

NIH-funded comparative trial will complete enrollment soon

full-color echocardiogram of the heart
Options for Mitral Regurgitation When Surgery Isn’t Ideal: The Maturing Roles of M-TEER

How Cleveland Clinic is helping shape the evolution of M-TEER for secondary and primary MR

two CT scans showing calcification of the mitral valve
Mitral Annular Calcification: Despite Its Challenges, Treatment Success Is Achievable

Optimal management requires an experienced center

Ad